At more than 60 percent quieter1, 30 percent lighter and 45 percent more compact than a standard generator2, the new Briggs & Stratton Q6500 QuietPower™ Series inverter generator3 introduces category-changing innovations to the generator market. Its fully-enclosed, impact-resistant shell significantly reduces noise and its lightweight compact design answers unmet needs among generator owners.
“We created a residential backup power source that drew upon the convenience and fuel efficiency inverters have brought to camping and tailgating events, but also increased the power output and value to serve the portable home backup market,” says Dan Roche, director of marketing, portable power and cleaning systems at Briggs & Stratton. “The Q6500 combines the best of inverter technology with enough wattage for total home power restoration.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8083851-briggs-stratton-q6500-quietpower-series-inverter-generator/
Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its presence at the American Association for Clinical Chemistry (AACC) 2016 Clinical Lab Expo today by featuring several next-generation diagnostic testing platforms and a new virtual reality experience that gives attendees an “under the hood” look at a lab of the future and an innovative concept Roche calls the “Roche connected lab.”
The virtual reality theater will enable attendees to view samples moving through a virtual lab equipped with various configurations of Roche automation, chemistry/immunoassay platforms and molecular diagnostics systems, as well as connections to third-party platforms. The actual Roche systems that are part of the connected lab concept will also be on display in the booth.
To view the multimedia release go to:
http://www.multivu.com/players/English/7889151-roche-aacc-2016/
If diagnosed early enough 90% of melanoma cases can be treated effectively. An exclusive study carried out by Ipsos for La Roche-Posay in 23 countries across all continents looks into the different attitudes to the sun and general knowledge of the risks associated with exposure. A massive 88% of those questioned are aware of the risks of developing skin cancer when exposed without protection to the sun. However, just 1 in 2 of those questioned have ever consulted a dermatologist for a mole screening and 1 in 4 of them have never even checked their own moles on their body.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7438251-la-roche-posay-become-skin-checker/
Roche announced today the U.S. introduction of the cobas b 123 POC system, a mobile blood gas analyzer designed for hospital point of care settings. The system’s next-generation technology helps ensure reliable performance by virtually eliminating the introduction of blood clots that can contribute to analyzer downtime and negatively impact patient care.
To view Multimedia News Release, go to https://www.multivu.com/mnr/57116-roche-cobas-b-123-poc-system-mobile-blood-gas-analyzer-hospital-technology
ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the ACCU-CHEK® Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents a significant advancement in blood glucose meter technology for people with diabetes who take multiple daily insulin injections. The meter’s integrated bolus calculator provides easy-to-use and reliable dose recommendations based on automated calculations, eliminating the need for manual dosing calculations and estimations.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322751-roche-accu-chek-aviva-expert-blood-glucose-meter-now-available/
Briggs & Stratton Power Products Group (NYSE: BGG), a leading manufacturer of outdoor power cleaning products, is taking its show on the road during the spring cleaning season. The Briggs & Stratton Grime To Shine Power Tour will make stops at 47 Lowe’s stores in 11 states to give customers the opportunity to demo the company’s pressure washer products.
“Whether you’re a new homeowner with little outdoor cleaning experience, a DIYer who takes pride in maintaining your home and property, or a professional contractor looking for a reliable commercial pressure washer, Briggs & Stratton has a cleaning system to accomplish your goals,” said Dan Roche, marketing director for Briggs & Stratton’s Portable Power and Cleaning Systems division. “At the Briggs & Stratton Grime To Shine Power Tour events, we’ll have pressure washers available for customers to test and get a first-hand feel for how easy it is to get some serious cleaning done.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7786151-briggs-stratton-grime-to-shine-power-tour/
In collaboration with the National Institutes of Health (NIH), Banner Alzheimer’s Institute (BAI), University of Antioquia in Colombia and Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announce the first-ever prevention trial in cognitively healthy individuals who are destined to develop Alzheimer’s disease because of their genetic history. This groundbreaking study—the first to investigate whether an anti-amyloid treatment can stave off the disease—will span two countries and help launch a new era of prevention research in the urgent fight against Alzheimer’s.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56128-banner-alzheimer-s-institute-genentech-nih-prevention-trial-genetics
